This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Russman, B.S. Articles by Barker, L. Search for Related Content PubMed PubMed Citation Articles by Russman, B.S. Articles by Barker, L. Social Bookmarking                         What's this?

Spinal Muscular Atrophy: New Thoughts on the Pathogenesis and Classification Schema

Newington Children's Hospital, Newington, CT

S.T. Iannacone, MD

Texas Scottish Rite Hospital, Dallas, TX

C.R. Buncher, ScD

University of Cincinnati Medical Center

F.J. Samaha, MD

University of Cincinnati Medical Center

M. White, MS

University of Cincinnati Medical Center

B. Perkins, RPT

Newington Children's Hospital, Newington, CT

L. Zimmerman, OTR

Newington Children's Hospital, Newington, CT

C. Smith, MS

Texas Scottish Rite Hospital, Dallas, TX

K. Burhans, OTR

Children's Hospital Medical Center, Cincinnati, OH

L. Barker, RPT

Children's Hospital Medical Center, Cincinnati, OH

We have established the first prospective, collaborative study of spinal muscular atrophy, the second most common neuromuscular disease of childhood. One hundred and forty-one patients have been evaluated on at least four occasions over a 3-year period. The patients have been grouped by age of onset, as well as by function at the time of initial evaluation. The muscle strength of 96 patients aged 5 years or older was evaluated at 6-month intervals using a fixed myometry system. The new observations made are: (1) The present classification schema is not valid; for example, 49 patients with onset of weakness before 6 months of age (type I or Werdnig-Hoffmann disease), whose life span is said to be only 2 to 4 years, participated in the study and are 4 months to 31 years of age. (2) Thirty-seven patients were evaluated over an 18-month period. None lost strength during this time but four lost function. Although the period of observation was short, the results suggest that the loss of function in patients with spinal muscular atrophy might be explained by a process other than cell death that allows patient strength to be maintained and simultaneously prevents the motor unit from achieving its normal adult potential. (J Child Neurol 1992;7:347-353).

Journal of Child Neurology, Vol. 7, No. 4, 347-353 (1992)
DOI: 10.1177/088307389200700403


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. Montes, A. M. Gordon, S. Pandya, D. C. De Vivo, and P. Kaufmann Clinical Outcome Measures in Spinal Muscular Atrophy J Child Neurol, August 1, 2009; 24(8): 968 - 978. [Abstract] [PDF]

				F. Deymeer, P. Serdaroglu, Y. Parman, and M. Poda Natural history of SMA IIIb: Muscle strength decreases in a predictable sequence and magnitude Neurology, August 26, 2008; 71(9): 644 - 649. [Abstract] [Full Text] [PDF]

				B. S. Russman Spinal Muscular Atrophy: Clinical Classification and Disease Heterogeneity J Child Neurol, August 1, 2007; 22(8): 946 - 951. [Abstract] [PDF]

				D. J. Sucato Spine Deformity in Spinal Muscular Atrophy J. Bone Joint Surg. Am., February 1, 2007; 89(suppl_1): 148 - 154. [Full Text] [PDF]

				M K M Hardart and R D Truog Spinal muscular atrophy-type I Arch. Dis. Child., October 1, 2003; 88(10): 848 - 850. [Full Text] [PDF]

				F. Cheliout-Heraut, A. Barois, A. Urtizberea, L. Viollet, and B. Estournet-Mathiaud Evoked Potentials in Spinal Muscular Atrophy J Child Neurol, June 1, 2003; 18(6): 383 - 390. [Abstract] [PDF]

				S. T. Iannaccone and and the American Spinal Muscular Atrophy Randomize Outcome Measures for Pediatric Spinal Muscular Atrophy Arch Neurol, September 1, 2002; 59(9): 1445 - 1450. [Abstract] [Full Text] [PDF]

				M. K. M. Hardart, J. P. Burns, and R. D. Truog Respiratory Support in Spinal Muscular Atrophy Type I: A Survey of Physician Practices and Attitudes Pediatrics, August 1, 2002; 110(2): e24 - 24. [Abstract] [Full Text] [PDF]

				R. Falsaperla, G. Romeo, A. Di Giorgio, P. Pavone, E. Parano, and A. M. Connolly Long-Term Survival in a Child With Arthrogryposis Multiplex Congenita and Spinal Muscular Atrophy J Child Neurol, December 1, 2001; 16(12): 934 - 936. [Abstract] [PDF]

				S. T. Iannaccone, B. S. Russman, R. H. Browne, C. R. Buncher, M. White, and F. J. Samaha Prospective Analysis of Strength in Spinal Muscular Atrophy J Child Neurol, February 1, 2000; 15(2): 97 - 101. [Abstract] [PDF]

				R. G. Miller Clinical Trials in Motor Neuron Diseases J Child Neurol, March 1, 1999; 14(3): 173 - 179. [Abstract] [PDF]

				S. T. Iannaccone, M. White, R. Browne, B. Russman, R. Buncher, and F. J. Samaha Muscle Fatigue in Spinal Muscular Atrophy J Child Neurol, August 1, 1997; 12(5): 321 - 326. [Abstract] [PDF]

				K. Zerres and S. Rudnik-Schoneborn Natural History in Proximal Spinal Muscular Atrophy: Clinical Analysis of 445 Patients and Suggestions for a Modification of Existing Classifications Arch Neurol, May 1, 1995; 52(5): 518 - 523. [Abstract] [PDF]

				F.J. Samaha, C.R. Buncher, B.S. Russman, M.L. White, S.T. Iannaccone, L. Barker, K. Burhans, C. Smith, B. Perkins, and L. Zimmerman Pulmonary Function in Spinal Muscular Atrophy J Child Neurol, July 1, 1994; 9(3): 326 - 329. [Abstract] [PDF]